In experimental models of spinal cord damage in rats, early post-injury administration of the peptide was associated with marked improvements in neurological function
Human clinical trials with adequate sample sizes and randomized controlled designs are lacking
For instance, topical or intrauterine delivery of growth-promoting peptides has been trialed in other tissues
Risk buying research chemicals with questionable purity
Because BPC-157 and TB-500 are not approved by the FDA for human use, and are banned by WADA, there are legal, ethical, and safety risks
Whether you need expert advice or ongoing care, YA Medical is here to help you feel stronger, healthier, and more energized every day.